Skip to content
Screener

Integra LifeSciences IART United States — Total Revenues

Similar metrics at other companies

Xerox Holdings Corporation logo
XRXUnited States — Total Revenues
$1.05B+13.0%
EAF
EAFUnited States — Total Revenues
$51.55M+20.4%
News Corporation logo
NWSUnited States And Canada — Total Revenues
$1.09B+6.0%
Bristol-Myers Squibb logo
BMYUnited States — Total Revenues
$8.99B+5.5%
GATX logo
GATXUNITED STATES — Total Revenues
$254.75M+7.5%
EAF
EAFAmericas (excluding the United States) — Total Revenues
$16.78M-29.7%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.33B+38.0%
Enterprise value$3.08B+16.2%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Dollars in thousandsThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
United States$307,099$306,308$596,479$588,525
Europe42,57242,59482,53577,920
Asia Pacific48,69747,73293,90892,837
Rest of World20,39318,97137,75738,976
Total Revenues$418,761$415,605$810,679$798,258

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's united states — total revenues?
Integra LifeSciences (IART) reported united states — total revenues of $307.1M in Q2 2026.
How has Integra LifeSciences's united states — total revenues changed year-over-year?
Integra LifeSciences's united states — total revenues increased by 0.3% year-over-year, from $306.31M to $307.1M.
What is the long-term trend for Integra LifeSciences's united states — total revenues?
Over 4 years (2021 to 2025), Integra LifeSciences's united states — total revenues has grown at a 2.5% compound annual growth rate (CAGR), from $1.09B to $1.2B.
What does united states — total revenues mean?
This metric represents the total net revenue generated from products and services sold within the United States geographic market. It serves as a primary indicator of the company's domestic market penetration and demand for its medical technology portfolio. Tracking this figure allows investors to assess the performance of the core domestic business segment relative to international operations.

Ask your AI about Integra LifeSciences's united states — total revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude